Impact BioMedical Inc. (IBO)

Impact BioMedical Statistics

Total Valuation

IBO has a market cap or net worth of $8.21 million. The enterprise value is $29.89 million.

Market Cap	8.21M
Enterprise Value	29.89M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

IBO has 12.19 million shares outstanding. The number of shares has decreased by -60.60% in one year.

Current Share Class	12.19M
Shares Outstanding	12.19M
Shares Change (YoY)	-60.60%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	0.79%
Owned by Institutions (%)	4.14%
Float	11.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,165.45
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4,269.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.77

Financial Efficiency

Return on equity (ROE) is -405.44% and return on invested capital (ROIC) is -9.50%.

Return on Equity (ROE)	-405.44%
Return on Assets (ROA)	-8.24%
Return on Invested Capital (ROIC)	-9.50%
Return on Capital Employed (ROCE)	101.31%
Revenue Per Employee	$3,500
Profits Per Employee	-$19.24M
Employee Count	2
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

In the past 12 months, IBO has paid $33,000 in taxes.

Income Tax	33,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.21% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-71.21%
50-Day Moving Average	0.63
200-Day Moving Average	1.05
Relative Strength Index (RSI)	55.77
Average Volume (20 Days)	337,992

Short Selling Information

The latest short interest is 316,432, so 2.60% of the outstanding shares have been sold short.

Short Interest	316,432
Short Previous Month	163,694
Short % of Shares Out	2.60%
Short % of Float	2.70%
Short Ratio (days to cover)	1.11

Income Statement

In the last 12 months, IBO had revenue of $7,000 and -$38.47 million in losses. Loss per share was -$3.26.

Revenue	7,000
Gross Profit	-4,000
Operating Income	-4.17M
Pretax Income	-8.34M
Net Income	-38.47M
EBITDA	-4.16M
EBIT	-4.17M
Loss Per Share	-$3.26

Balance Sheet

The company has $624,000 in cash and $22.35 million in debt, giving a net cash position of -$21.73 million or -$1.78 per share.

Cash & Cash Equivalents	624,000
Total Debt	22.35M
Net Cash	-21.73M
Net Cash Per Share	-$1.78
Equity (Book Value)	-7.38M
Book Value Per Share	-0.85
Working Capital	-21.69M

Cash Flow

Operating Cash Flow	-4.43M
Capital Expenditures	n/a
Free Cash Flow	-4.43M
FCF Per Share	-$0.36

Margins

Gross Margin	-57.14%
Operating Margin	-59,514.29%
Pretax Margin	-549,828.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	60.60%
Shareholder Yield	60.60%
Earnings Yield	-471.59%
FCF Yield	-54.28%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IBO has an Altman Z-Score of -5.6 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.6
Piotroski F-Score	2